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We have previously reported that the addition of interferon (IFN) to the culture medium of Vero cells (which cannot produce IFN) that were
infected with the CPI− strain of parainfluenza virus 5 (PIV5, formally known as SV5), that fails to block IFN signaling, rapidly induces alterations
in the relative levels of virus mRNA and protein synthesis. In addition, IFN treatment also caused a rapid redistribution of virus proteins and
enhanced the formation of cytoplasmic viral inclusion bodies. The most studied IFN-induced genes with known anti-viral activity are MxA, PKR
and the Oligo A synthetase/RNase L system. We therefore examined the effects of these proteins on the replication cycle of PIV5. These studies
revealed that while these proteins had some anti-viral activity against PIV5 they were not primarily responsible for the very rapid alteration in
virus protein synthesis observed following IFN treatment, nor for the IFN-induced formation of virus inclusion bodies, in CPI− infected cells.
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Parainfluenza virus type 5 (previously known as simian virus
5; SV5) (Chatziandreou et al., 2004), is a prototype member of
the Rubulavirus genus in the Paramyxovirinae subfamily of the
family Paramyxoviridae (Lamb and Kolakofsky, 2001). PIV5,
like all other paramyxoviruses, is an enveloped, non-segmented
negative-stranded RNA virus. The helical nucleocapsid (rather
than free genomic RNA) acts as a template for all RNA
synthesis. The viral polymerase complex transcribes, in a
sequential manner, the NP, V/P, M, F, SH, HN and L genes, after
polymerase entry at the single 3′ promoter of the template, by a
“stop–start” transcription mechanism. Efficiency of transcrip-
tion decreases with increasing distance of the genes from the
promoter generating a transcriptional gradient, with the NP gene
transcribed most frequently and the L gene transcribed the least
frequently (reviewed in Whelan et al., 2004).
Interferon (IFN)-α/β are produced by cells in direct response
to virus infection and are characterized by their ability to induce⁎ Corresponding author. Fax: +44 1334 463397.
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secreted IFN-α/β bind to the IFN-α/β receptor on the surface of
the infected cells and neighboring cells to initiate an intracellular
signaling cascade that ultimately activates the expression of
hundreds of IFN-inducible genes. Some of the genes up-regu-
lated by IFN stimulation are involved in the establishment of an
antiviral state. Well characterized examples of IFN-induced
antiviral proteins include protein kinase R (PKR), the MxA
GTPases and the family of 2′-5′ oligoadenylate synthetases
(OAS) that activate the latent endoribonuclease L (RNase L).
PKR is a dsRNA activated, serine–threonine protein kinase
normally present in the cell in an inactive form (Williams, 1999).
PKR can mediate inhibition of protein synthesis through
phosphorylation of eukaryotic initiation factor-2α (eIF-2α),
which, in the course of viral infection, provides a defence
mechanism for restricting viral protein translation and, ulti-
mately, viral replication (Clemens and Elia, 1997; Meurs et al.,
1990). Mx proteins are dynamin-like large GTPases that have
antiviral activity and inhibit the multiplication of several RNA
viruses, in contrast to other IFN-stimulated genes, they are not
constitutively expressed in cells. The importance of Mx proteins
for host survival has been amply demonstrated (Arnheiter et al.,
167T.S. Carlos et al. / Virology 363 (2007) 166–1731996; Hefti et al., 1999; Kochs et al., 2002; Pavlovic et al.,
1995), but the mechanism of MxA antiviral action is still not
completely understood. The viral target recognised by MxA is
virus- and cell type-specific, and it can inhibit virus transcription
or mRNA translation, or interfere with viral ribonucleocapsid
protein complexes or transportation of virus nucleocapsids
(Haller and Kochs, 2002). The OAS system consists of enzymes
that, when activated by dsRNA, catalyze the synthesis of
oligoadenylates whose function is to activate latent RNase L,
which degrades ssRNA, including both viral and cellular
mRNA, thereby blocking protein synthesis and leading to viral
inhibition (Zhou et al., 1997).
Many paramyxoviruses have been shown to at least partially
circumvent the IFN response by blocking IFN signaling and
limiting IFN production. PIV5 blocks IFN signaling by targeting
STAT1, a host cell transcription factor essential for both IFN-α/β
and IFN-γ signaling, for proteasome-mediated degradation
(Didcock et al., 1999a, 1999b). The V protein of PIV5 also helps
to limit IFN production by interacting with, and inhibiting the
action of, mda-5, an intracellular signalingmolecule which plays
a key role in at least one intracellular signaling pathway that
leads to the induction of IFN (Andrejeva et al., 2004). However,
the ability of PIV5 to circumvent the IFN response is not
absolute as infected cells still release some IFN, which can
induce an antiviral state in neighboring uninfected cells, thereby
restricting the replication of PIV5 (Andrejeva et al., 2002;
Chatziandreou et al., 2004; Didcock et al., 1999a;Wansley et al.,
2005). In support of these observations, PIV5 replication was
shown to be enhanced in cells that have been engineered to be
non-responsive to IFN (Young et al., 2003). We have recently
described a model in which it is possible to study the kinetics of
IFN-induced effects on PIV5 transcription, protein synthesis and
the distribution of virus proteins, in the absence of virus
countermeasures. In this model, CPI−, a canine strain of PIV5
that fails to block IFN signaling, was used to infect Vero cells,
which are unable to produce IFN due to spontaneous geneFig. 1. CPI− protein synthesis profile in Vero, Hep2 naive, Hep2/BVDV-NPro and H
cells (B) were infected with CPI− or CPI+, and Hep2/BVDV-NPro and Hep2/PIV5-V
either treated with exogenous rHuIFN-α at 12 h p.i. or left untreated. Cells were met
proteins were immunoprecipitated from extracts of these cells with a pool of antibodie
separated on a 4–12% gradient PAG and visualized by phosphorimager analysis.deletions (Desmyter et al., 1968; Mosca and Pitha, 1986) but can
respond to exogenous IFN supplemented to culture medium. It
was shown that addition of IFN to CPI− infected cells, once
virus replication was established, rapidly changed the profile of
virus transcription and protein synthesis. IFN increased the
steepness of the virus mRNA transcription gradient and the
production of virus mRNAs with longer poly(A) tails, which
suggests that the virus polymerase processivity may be altered in
cells in an IFN-induced antiviral state (Carlos et al., 2005).
Although not in complete concordance with mRNA levels, IFN
also caused an alteration in the protein synthesis pattern such that
there was a marked down-regulation in the expression levels of
genes downstream of the V/P gene. Furthermore, IFN treatment
led to a redistribution of virus proteins within infected cells that
resulted in the formation of inclusion bodies (Carlos et al., 2005).
In this report we attempt to further define how IFN mediates
these effects, and demonstrate that although PKR, oligo A/
RNase L and MxA have some anti-viral activity none of them
appears to be primarily responsible for the rapid IFN-induced
alterations in the PIV5 replication cycle.
Results
Comparison of the effects of IFN on CPI− virus protein
synthesis in Hep2 and Vero cells
To ascertain whether similar IFN-induced changes in the
pattern of protein synthesis observed in Vero cells infected with
CPI− occurred in cells that can produce and respond to IFN, we
examined the replication of CPI− in human Hep2 cells. Vero and
Hep2 cells were mock infected or infected with CPI− or CPI+
(the parental virus that blocks IFN signalling) and either treated
with IFN at 12 h p.i. or left untreated. Six hours after IFN
treatment, cells were metabolically labeled with [35S] methionine
for 1 h and the relative levels of newly synthesized viral proteins
were estimated by immunoprecipitation (Figs. 1A and B). It wasep2/PIV5-V cells, in the absence and presence of IFN. Vero (A) and Hep2 naïve
cells (C) were infected with CPI−. Cells were infected at m.o.i. of 50 pfu/cell and
abolically labeled with [35S]-methionine for 1 h, 6 h after addition of IFN. Virus
s to the NP, P, M, HN and L proteins. The precipitated proteins were subsequently
Fig. 2. Effect of VV E3L or influenza virus NS1 expression on CPI− protein
synthesis in Hep2 cells. Hep2 naïve, Hep2/E3L, Hep2/NS1 and Hep2/PIV5-V
cells were infected with CPI− at an m.o.i. of 50 pfu/cell and 12 h later treated
with IFN (or left untreated). Detection of phosphorylated eIF-2α (eIF-2α-P)
by immunoblot analysis (A). Metabolic labeling with [35S]-methionine for
1 h at 18 h p.i. and immunoprecipitation of viral proteins (B). The labeled
proteins were separated by SDS-PAGE and visualized by phosphorimager
analysis.
Fig. 3. CPI− virus yield in naïve Hep2, Hep2/PIV5-V, Hep2/E3L, Hep2/NS1,
Hep2/BVDV-NPro cells. Amount of infectious virus released from naïve Hep2
cells and from various Hep2 cells expressing different IFN antagonists, which
have been infected with CPI− at high m.o.i. Hep2/BVDV-NPro cells were or
were not treated with exogenous IFN at 12 h p.i.
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synthesis in untreated Hep2 cells was very similar to that
observed in Vero cells infected with CPI− and treated with
IFN. Thus, while the level of expression of NP, P and V was
high, there was markedly reduced M, HN and L expression.
Given that Hep2 cells produce IFN upon virus infection, it
was not surprising that addition of exogenous IFN at 12 h p.
i. cells had no additional effect on the pattern of viral protein
synthesis. In contrast, and as expected given that CPI+
blocks IFN signaling, the pattern of CPI+ protein synthesis
was not affected in Hep2 cells, even though these cells can
produce and respond to IFN. To confirm that the unusual
pattern of CPI− protein synthesis was due to Hep2 cells
producing and responding to IFN we engineered Hep2 cells
to constitutively express either a functional V protein of
PIV5 that blocks IFN signaling (Hep2/PIV5-V cells) or NPro
of BVDV (Hep2/BVDV-NPro), which targets IRF-3 for
proteasome degradation and thus blocks IFN production
(Hilton et al., 2006). In contrast to naive Hep2 cells, a
normal pattern of CPI− virus protein synthesis was observed
in Hep2/PIV5-V cells, both in the presence and absence of
exogenous IFN, as well as in Hep2/BVDV-NPro cells in the
absence of IFN. However, in a similar manner to that
observed in Vero cells, addition of exogenous IFN to Hep2/
BVDV-NPro cells induced a rapid change in the pattern of
CPI− virus protein synthesis (Fig. 1C).The role of PKR and oligo A synthetase/RNase L in altering the
pattern of CPI− protein synthesis
As part of the ongoing studies within our group, Hep2
polyclonal cell lines expressing IFN antagonists have been
isolated, these include the E3L (Hep2/E3L; Hilton et al., 2006)
and NS1 (Hep2/NS1) proteins of vaccinia virus and Influenza A
virus (strain PR8; Hale et al., 2006), respectively. The E3L and
NS1 proteins both bind dsRNA and interact with PKR to inhibit
its activity. To determine whether constitutive expression of
either NS1 or E3L in Hep2 cells inhibited the activity of PKR,
we examined whether or not eIF2-α was phosphorylated in
these cells following infection with CPI−. These results clearly
showed that the levels of phosphorylated eIF-2α were strongly
reduced in Hep2/E3L and Hep2/NS1 cells compared to Hep2
naive cells (Fig. 2A). Therefore we next compared the patterns
of CPI− protein synthesis in Hep2/E3L and Hep2/NS1 cells to
naive Hep2 cells and Hep2 cells constitutively expressing the V
protein of PIV5 (Hep2/PIV5-V). The cells were infected with
CPI− at a high m.o.i., treated with IFN at 12 h p.i. (or left
untreated) and 6 h later the cells were metabolically labeled with
[35S]-methionine for 1 h. The relative levels of virus protein
synthesis were estimated by immunoprecipitation (Fig. 2B).
Although the ratio of M and HN proteins compared to NP and P
proteins synthesized in Hep2/E3L and Hep2/NS1 cells was
slightly higher than in naive Hep2 cells, the expression of M and
HN was significantly reduced compared to Hep2/PIV5-V cells.
These results suggest that although inhibition of PKR may
weakly enhance viral gene expression it does not appear to be
primarily responsible for the IFN-induced changes in CPI−
virus protein synthesis.
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protein synthesis in Hep2 cells, we next compared the
production of infectious virus in naive Hep2 cells and in
Hep2 cells constitutively expressing the different IFN antago-
nists (Fig. 3). Cells were infected at high m.o.i. and the amount
of virus released monitored up to 72 h p.i. These results showed
that there was approximately 100-fold increase in the titer of
CPI− in Hep2 cells that had been engineered either not to
produce IFN (Hep2/BVDV-NPro cells) or respond to IFN
(Hep2/PIV5-V cells) compared to either naive Hep2 cells or
Hep2/BVDV-NPro cells treated with exogenous IFN at 12 h p.i.
Expression of the NS1 protein of influenza virus improved the
yield approximately 10-fold. However, expression of E3L did
not significantly improve virus growth.
These results suggested that PKR was not responsible for the
major alterations in virus protein synthesis observed when CPI−
infected cells were exposed to IFN. Furthermore, since both
E3L and NS1 have also been reported to inhibit the oligo A/
RNase L system (Beattie et al., 1995; Min and Krug, 2006),
these results also imply that the oligo A/RNase L system is not
responsible for these IFN-induced effects on the replication
cycle of PIV5. In order to address this question further, we
examined the affect of IFN on the pattern of CPI− virus protein
synthesis in naive Hep2 and Hep2/BVDV-NPro cells that had or
had not been treated with siRNA to PKR or RNase L prior to
infection (Fig. 4). siRNA treatment successfully reduced the
levels of both PKR and RNase L and also prevented the levelsFig. 4. Effect of siRNA knockdown of RNase L or PKR on CPI− protein synthesis
BVDV-NPro cells, respectively, were treated with either siRNAs to RNase L, PKR o
(50 pfu/cell) and exogenous IFN was or was not supplemented to Hep2/BVDV-NPro
1 h at 18 h p.i.. The labeled viral proteins were immunoprecipitated, separated by SD
RNase L or PKR and levels of actin were monitored by immunoblot analysis of
respectively) using specific antibodies for these proteins.of PKR and RNase L increasing upon IFN treatment. Never-
theless, treatment of cells with siRNA to PKR or RNase L did
not prevent IFN treatment from rapidly altering the pattern of
virus protein synthesis, in a similar manner to that observed in
siRNA-untreated Hep2/BVDV NPro cells. Furthermore, the M,
HN or L levels did not increase in siRNA-treated naive cells
compared to untreated cells (Fig. 4). These results also suggest
that the IFN-induced rapid change in the pattern of CPI− protein
synthesis is not due to the antiviral actions of PKR or RNase L.
MxA reduces the yield of virus but is not responsible for the
rapid alteration in CPI− virus protein synthesis induced by
IFN
Since Hep2 cells are deficient in MxA expression (Fig. 5A)
the results presented above also suggested that MxA may not
play a significant role in the gross changes seen in the pattern of
CPI− in the presence of IFN. However, IFN not only induces a
change in CPI− virus protein synthesis but also induces a
redistribution of virus nucleocapsid proteins into large cyto-
plasmic inclusion bodies. Since it has been reported for other
viruses, including La Crosse virus, that MxA sequesters
nucleocapsids into elongated tubular structures resulting in
cytoplasmic inclusions, we examined in more detail how MxA
affects the CPI− replication cycle. In these experiments the
replication of CPI− in naive Vero cells, that do not express MxA
in the absence of IFN, was compared with Vero cells that havein naïve Hep2 and Hep2/BVDV/NPro cells. (A and B) Naïve Hep2 and Hep2/
r DDB1 (control) for 30 h. The cells were then infected with CPI− at high m.o.i.
cells at 12 h p.i. The cells were metabolically labeled with [35S]-methionine for
S-PAGE and visualized by phosphorimager analysis. (C and D) The depletion of
total cell extracts (of the same infected cell extracts used in panels A and B,
Fig. 5. MxA is not responsible for the observed decrease of the relative levels of CPI− protein synthesis in the presence of IFN. (A) Hep2 cells do not express
endogenous MxA protein. Vero cells and Hep2 cells were mock-infected or infected with CPI− at high m.o.i. (50 pfu/cell) and treated with IFN at 8 h p.i. or left
untreated. At 24 h p.i. the cells were lysed and the proteins contained in total cell extracts were separated by SDS-PAGE. Immunoblot analysis was subsequently
performed using polyclonal anti-MxA antibody. (B) Naïve cells and MxA-expressing Vero cells were infected with CPI− at an m.o.i. of 50 pfu/cell, and at 12 h p.i. the
cells were, or were not, treated with exogenous IFN. Six and twelve hours later cells were metabolically labeled with [35S]-methionine for 1 h. Virus proteins were
immunoprecipitated, separated by SDS-PAGE and visualized by phosphorimager analysis. (C) Naïve and MxA-expressing Vero cells were infected with CPI− at high
m.o.i. (50 pfu/cell) and at 12 h p.i. the mediumwas (+IFN), or was not (−IFN), supplemented with IFN. The cell monolayers were fixed at 1 and 3 days p.i. and stained
for MxA and NP/P.
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(Frese et al., 1996; Stertz et al., 2006; Fig. 5B). Naive and MxA-
expressing Vero cells were infected with CPI− at a high m.o.i.
and 12 h later IFN was, or was not, added to the culture medium.
At 6 and 12 h after IFN treatment, the cells were metabolically
labeled with [35S]-methionine and the relative levels of virus
proteins were estimated by immunoprecipitation (Fig. 5B).
Although in the absence of IFN treatment there was a slight
apparent reduction in HN expression in MxA-expressing cells,
the pattern of virus protein synthesis remained relatively normal
in the MxA-expressing Vero cells. However, in both cell types
IFN induced a rapid change in the pattern of virus protein
synthesis such that there was an obvious reduction in the relative
levels of M, HN and L protein synthesis, but not NP and P.
Although these studies showed that MxA does not have a
dramatic effect on CPI− protein synthesis, it may still affect
other stages of the PIV5 replication cycle, such as the
distribution of NP and P proteins. To address this question,
naive Vero and MxA-expressing Vero cells were infected withCPI− and were, or were not, treated with IFN at 12 h p.i. At 1
and 3 days p.i. the cells were fixed and stained for the cellular
MxA protein and the viral NP and P proteins. As shown in Fig.
5C, MxA does not induce inclusion body formation at 1 day p.i.
and the relatively diffuse distribution of NP and P proteins
observed in MxA-expressing Vero cells was similar to that
observed in naive infected cells. However, following the
addition of IFN to both naive and MxA-expressing cells, NP
and P proteins redistributed into distinct cytoplasmic inclusion
bodies. Furthermore, MxA did not obviously co-localize with
the viral inclusion bodies and was diffusely distributed through-
out the cytoplasm both in IFN-treated and untreated cells (data
not shown). However, by 3 days p.i., there was a clear differ-
ence in the distribution of NP and P proteins in MxA-expressing
cells in comparison with non-MxA-expressing cells; there was
more NP and P in inclusion bodies when MxA was being
expressed (Fig. 5C, right panel), although there was still no
apparent co-localization of MxA with the NP and P protein
accumulations (data not shown).
Fig. 6. Effect of MxA and IFN on CPI− virus yield. Amount of infectious virus
released from naive and Vero-control (VN36) cells that were or were not treated
with IFN at 12 h p.i., and from MxA-expressing Vero cells, that had been
infected with CPI− at high m.o.i. (50 pfu/cell).
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times post infection, immunofluorescence data suggested that
MxA may be affecting virus replication at later times. To
ascertain whether this late effect may influence the production
of infectious virus, naive and MxA-expressing Vero cells, as
well as an additional control Vero cell-line termed VN36 (that
was generated at the same time as the MxA-expressing cells
using a non-expressing plasmid; Frese et al., 1995) were
infected with CPI− at a high m.o.i. and virus growth was
determined (Fig. 6). The results obtained showed that, in the
absence of exogenous IFN, CPI− virus titers were reduced
approximately 10-fold in MxA-expressing cells in comparison
to naive cells (Fig. 6). However, addition of IFN at 12 h p.i. had
a stronger effect on CPI− growth, such that by 108 hrs p.i. CPI−
virus titers in IFN treated cells were reduced approximately
1000-fold in comparison to untreated cells (Fig. 6).
Discussion
We have previously reported that IFN alters the replication
cycle of PIV5 in Vero cells by inducing an antiviral response
which changes the pattern of PIV5 transcription and protein
synthesis and results in an altered distribution of virus proteins
(Carlos et al., 2005). To determine whether the same IFN-
induced anti-viral mechanisms operate in other cells, we
engineered Hep2 cells to constitutively express BVDV NPro,
which targets IRF-3 for proteasome-mediated degradation and
thus blocks the ability of the cells to produce IFN in response to
virus infection (Hilton et al., 2006). However, since NPro does
not block IFN signaling, the engineered cells can still respond to
exogenous IFN. In Hep2/BVDV-NPro cells infected with CPI−
a normal pattern of virus protein synthesis was observed, but
this was rapidly altered, in a manner similar to that observed in
Vero cells infected with CPI−, upon the addition of IFN to theculture media. In naive Hep2 cells, because they produce and
respond to IFN in response to CPI− infection, this IFN-induced
pattern of virus protein synthesis was seen even without addition
of exogenous IFN. Furthermore, we have observed similarly
altered patterns of CPI− protein synthesis in a variety of tissue
culture cells that produce and respond to IFN (data not shown).
The question therefore remains as to whether this IFN-induced
alteration in the pattern of virus protein synthesis is simply an
unavoidable consequence of the mode of replication of PIV5
(and other rubulaviruses/paramyxoviruses; Carlos et al., 2005),
or whether it has been evolutionarily selected for, perhaps either
to ensure sufficient V protein is made to dismantle the IFN-
induced anti-viral state of cells (by rapidly targeting STAT1 for
degradation (Didcock et al., 1999b; unpublished observations),
or to allow PIV5 to establish prolonged or persistent infections
as we have previously suggested (Carlos et al., 2005).
IFN-α/β activate the expression of more than 300 ISGs,
many of which have direct or indirect anti-viral activities. Of
those with proven antiviral activity, PKR, OAS and Mx proteins
are probably the best studied. Indeed, transgenic mice deficient
in these responses are in general more susceptible to a variety of
viruses (Abraham et al., 1999; Arnheiter et al., 1996; Zhou et
al., 1997). However, mice lacking PKR, RNase L and Mx are
still capable of mounting a limited IFN-induced anti-viral res-
ponse, demonstrating that there must be additional IFN-induced
anti-viral proteins (Zhou et al., 1999). The results presented here
are thus somewhat surprising in that they demonstrate that PKR,
OAS/RNase L and MxA alone are not responsible for the major
changes in PIV5 transcription and protein synthesis observed in
cells in an IFN-induced anti-viral state, although we cannot rule
out the possibility that they may act in concert with other IFN-
induced proteins to mediate these effects. Nevertheless, MxA
appears to have some anti-PIV5 activity as, at late times p.i.,
there was a difference in the distribution of the NP and P
proteins in Vero and Vero-MxA cells, suggesting that MxA can
directly or indirectly induce late formation of inclusion bodies.
Furthermore, the yield of virus fromMxA-expressing Vero cells
was ten-fold lower than from naive Vero cells. The antiviral
activities of PKR and RNase L against PIV5 are less obvious.
Thus, although the expression levels of M, HN, and L proteins
were enhanced in Hep2/VV-E3L and Hep2/Flu-NS1 cells (in
which PKR activity was inhibited), their levels were still
significantly lower than in Hep2/BVDV-NPro or Hep2/PIV5-V
cells. Furthermore, treatment of Hep2 cells, or Hep2/BVDV-
NPro cells with siRNA to RNase L or PKR prior to infection did
not alter the IFN-induced pattern of CPI− protein synthesis. On
the other hand the yield of virus from Hep2/Flu-NS1 cells was a
ten-fold higher than in naive Hep2 cells. However, since NS1 is
a multifunctional protein, it is possible that the improvement in
CPI− replication observed in Hep2/Flu-NS1 cells may be due to
another property of NS1, e.g. its ability to activate PI3 kinase
(Hale et al., 2006) or limit IFN production (Garcia-Sastre et al.,
1998), rather than its ability to block PKR (or oligo A/RNase L)
activity. Thus it is still not clear which IFN-induced proteins are
responsible for the changes in PIV5 transcription and protein
synthesis. However, since IFN primarily induces a specific
alteration in the pattern of PIV5 protein synthesis (rather than
172 T.S. Carlos et al. / Virology 363 (2007) 166–173simple proportionate reduction in the levels of synthesis of all
virus proteins), it is likely that this IFN-induced effect will be
mediated by a protein(s) which specifically alter(s) a virus
component of the PIV5 replication cycle, e.g. the polymerase
(Carlos et al., 2005), rather than proteins, such as PKR and
OAS/RNase L, that have global effects on protein synthesis or
mRNA stability.
Materials and methods
Cells, viruses and interferon
Vero and Hep2 cells, and their derivatives were grown as
monolayers in 25 cm2 or 75 cm2 tissue culture flasks, in
Dulbecco's modified Eagle's medium (DMEM) supplemented
with 10% newborn calf serum or fetal bovine serum (growth
medium) at 37 °C. When required, cells were treated with
recombinant human interferon-α2a [rHuIFN-α (Roferon-A;
Roche)] at 1000 units/ml. PIV5 strains CPI− and CPI+
(Baumgartner et al., 1982, 1987; Evermann et al., 1981) were
grown and titrated under appropriate conditions in Vero cells.
CPI− and CPI+ infection and IFN treatment time course
Cell monolayers were infected with CPI− or CPI+ (the
parental strain of CPI− that blocks IFN signaling; Chatzian-
dreou et al., 2002) strains of PIV5 at an m.o.i. of 50 to 100 pfu/
cell (or mock-infected). After an adsorption period of 1–2 h on a
rocking platform at 37 °C, the virus inoculum (or growth
medium, for mock infections) was removed and replaced with
fresh maintenance medium (DMEM containing 2% newborn
calf serum or fetal bovine serum). At 12 h p.i. the medium was
either supplemented with rHuIFN-α or left untreated as a
control. Cells were incubated for a further 6 or 12 h (as indicated
in each experiment) and then harvested for protein analysis, as
described below.
siRNA interference
Hep2 naïve cells and Hep2 cells that constitutively express
the NPro protein of bovine viral diarrhea virus (Hep2/BVDV-
NPro) were transfected with either a pool of siRNAs specific for
human RNase L (SMART pool; Dharmacon Research, Lafay-
ette, CO) or a siRNA targeting human PKR (siRNA PKR
duplex; Dharmacon Research, Lafayette, CO). The final
concentration of siRNA was 100 nM and the transfection
reagent used was Oligofectamine (Invitrogen). At 30 h after
transfection, the cells were infected with CPI− and treated or not
treated with IFN for 6 h, as described above. Immunoblotting
analysis (described below) was performed to measure the levels
of RNase L, PKR and actin.
Immunoprecipitation, immunoblotting and
immunofluorescence
The procedures for immunoblotting, immunofluorescence
and immunoprecipitating radioactively labeled proteins havepreviously been described (Carlos et al., 2005; Randall and
Dinwoodie, 1986). Antibodies used in these procedures
included monoclonal antibodies (mAbs) to the NP, P, M and
HN proteins of PIV5 (Randall et al., 1987) and a polyclonal
antiserum to the P and V proteins of PIV5 (Carlos et al., 2005).
MxAwas detected with a polyclonal anti-MxA antibody (kindly
provided by G. Kochs, University of Freiburg, Germany). The
phosphorylated form of eIF-2α (eIF-2α-P) was detected with a
rabbit anti-Phospho-eIF-2α (Ser51) antibody (Cell signalling).
PKR was detected using a rabbit polyclonal anti-PKR (Santa
Cruz Biotechnology) and RNase L was detected using a mouse
monoclonal anti-RNase L antibody (Zymed Laboratories Inc.).
Actin was detected using a mouse monoclonal anti-β-Actin
antibody (Sigma).
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